RTP Mobile Logo


Track 1: Clinical care of patients with lung cancer amid the COVID-19 pandemic — Dr Liu
Track 2: Case (Dr Liu): A woman in her early 60s with Stage IV non-small cell lung cancer (NSCLC) and an EGFR exon 19 deletion receives osimertinib as first-line therapy and develops COVID-19
Track 3: Case (Dr Liu): A woman in her mid-60s with severe dyspnea is diagnosed with small cell lung cancer and COVID-19
Track 4: Case (Dr Liu): A man in his early 60s presents with metastatic NSCLC and an EGFR mutation
Track 5: Risk of complications with immunotherapy and chemotherapy during the COVID-19 pandemic
Track 6: Impact of COVID-19 on the care of patients with lung cancer; role of telemedicine
Track 7: Long-term effects of COVID-19 on clinical research and new advances
Track 8: Treatment of breast cancer during the COVID-19 pandemic — Dr Traina
Track 9: Case (Dr Traina): A woman in her mid-60s receiving treatment for HER2-positive metastatic breast cancer tests positive for COVID-19
Track 10: Case (Dr Traina): A woman in her early 50s with triple-negative breast cancer experiences severe symptoms with COVID-19
Track 11: Effect of the pandemic on palliative care; novel agents and management approaches for patients with COVID-19
Track 12: Patterns of cancer treatment during the pandemic
Track 13: Role of telemedicine in the monitoring and care of patients with cancer
Track 14: Gastrointestinal cancers in the COVID-19 era — Dr Bekaii-Saab
Track 15: Case (Dr Bekaii-Saab): A woman in her early 60s with pancreatic neuroendocrine cancer and liver metastases develops COVID-19
Track 16: Case (Dr Bekaii-Saab): A man in his early 70s receiving FOLFIRI/binimetinib for microsatellite stable, RAS/RAF wild-type colon cancer recovers after severe COVID-19
Track 17: Changes in patterns of care for patients with gastrointestinal cancers during the COVID-19 pandemic
Track 18: Challenges with the use of chemotherapy and immunotherapy for patients with cancer in the COVID-19 era
Track 19: Management of genitourinary cancers during the COVID-19 era — Dr Oh
Track 20: Case (Dr Oh): A man in his early 80s with metastatic castration-resistant prostate cancer tests positive for SARs-CoV-2
Track 21: Case (Dr Oh): A man in his early 70s is diagnosed with metastatic renal cell carcinoma amid the COVID-19 pandemic
Track 22: Risk factors for complications from COVID-19; emerging mechanism for the protective effects of androgen deprivation therapy
Track 23: Impact of the pandemic on the care of patients with genitourinary cancers
Track 24: Effects of COVID-19 on the care of patients with cancer and on cancer research
Track 25: New advances and emerging options for the management of COVID-19
Tanios Bekaii-Saab, MD
Professor, Mayo Clinic College of Medicine and Science
Program Leader, Gastrointestinal Cancer, Mayo Clinic Cancer Center
Consultant, Mayo Clinic in Arizona
Phoenix, Arizona
Stephen V Liu, MD, PhD
Associate Professor of Medicine
Georgetown University Hospital
Washington, DC
William K Oh, MD
Chief, Division of Hematology and Medical Oncology
Professor of Medicine and Urology
Ezra M Greenspan, MD Professor in Clinical Cancer Therapeutics
Icahn School of Medicine at Mount Sinai
Associate Director of Clinical Research
The Tisch Cancer Institute
Mount Sinai Health System
New York, New York
Tiffany A Traina, MD
Vice Chair, Department of Medicine
Associate Attending Physician
Section Head, Triple-Negative Breast Cancer Clinical Research Program
Memorial Sloan Kettering Cancer Center
Associate Professor of Medicine
Weill Cornell Medicine
New York, New York
Neil Love, MD
Research To Practice
Miami, Florida